Effect of valine on the control of fatty acid synthesis in white adipose tissue of the rat.
In adipocytes from fed rats, the rate of fatty acid synthesis in the presence of glucose and insulin was inhibited 40% by valine (5 mm). tthis inhibition was largely abolished by the addition to the incubation medium of the transaminase inhibitor aminooxy acetate, and of pyruvate and agents which raise the intracellular pyruvate levels such as N,N,N1,N1-tetramethyl-p-phenylenediamine. Pyruvate output into the incubation medium from fat pads obtained from fed rats and incubated with glucose and insulin was decreased significantly by the addition of valine. When adipocytes were incubated under similar conditions, the final concentration of pyruvate in the incubation medium was 42 +/- 1.6 muM under control conditions and approximately one third of this value in the presence of 2.5 mM valine. Valine had no significant effect on pyruvate dehydrogenase (lipoate) (EC 1.2.4.1) activity when assayed in homogenates prepared from adipose tissue previously incubated for 60 min with the amino acid. Although the ketoacid analogue of valine alpha-ketoisovaleric acid, is a competitive inhibitor of pyruvate dehydrogenase (lipoate) (K1 = 1.4 mM), this cannot solely account for the valine-induced reduced rate of lipogenesis. Rather, the mechanism involves a reduction in pyruvate concentration and thereby a diminished flow through pyruvate dehydrogenase (lipoate). Details of the possible mechanism are discussed.
D000273:Adipose Tissue / Q000378:metabolism*; D000625:Aminooxyacetic Acid / Q000494:pharmacology; D000818:Animals; D005227:Fatty Acids / Q000096:biosynthesis*; D005947:Glucose / Q000494:pharmacology; D005990:Glycerol / Q000378:metabolism; D045782:Hemiterpenes; D007328:Insulin / Q000494:pharmacology; D007651:Keto Acids / Q000494:pharmacology; D007773:Lactates / Q000378:metabolism; D008297:Male; D011768:Pyruvate Dehydrogenase Complex / Q000378:metabolism; D011773:Pyruvates / Q000378:metabolism; D051381:Rats; D013772:Tetramethylphenylenediamine / Q000494:pharmacology; D014631:Valerates / Q000494:pharmacology; D014633:Valine / Q000494:pharmacology*
D005227:Fatty Acids; D045782:Hemiterpenes; D007328:Insulin; D007651:Keto Acids; D007773:Lactates; D011768:Pyruvate Dehydrogenase Complex; D011773:Pyruvates; D014631:Valerates; D000625:Aminooxyacetic Acid; C001505:alpha-ketoisovalerate; D014633:Valine; D005947:Glucose; D013772:Tetramethylphenylenediamine; D005990:Glycerol